89bio, Inc. financial data

Symbol
ETNB on Nasdaq
Location
142 Sansome Street, Second Floor, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64K % +29.3%
Debt-to-equity 12.4 % -23.2%
Return On Equity -35.4 % +11%
Return On Assets -31.5 % +8.05%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 106M shares +40.3%
Common Stock, Shares, Outstanding 105M shares
Entity Public Float 1.18B USD +3767%
Common Stock, Value, Issued 105K USD +40%
Weighted Average Number of Shares Outstanding, Basic 99.8M shares +34.7%
Weighted Average Number of Shares Outstanding, Diluted 99.8M shares +34.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 157M USD +59.7%
General and Administrative Expense 34M USD +38.2%
Operating Income (Loss) -191M USD -55.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -171M USD -43.8%
Income Tax Expense (Benefit) 134K USD
Net Income (Loss) Attributable to Parent -175M USD -47.2%
Earnings Per Share, Basic -1.96 USD/shares -30.7%
Earnings Per Share, Diluted -1.96 USD/shares -30.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 212M USD -13.5%
Marketable Securities, Current 319M USD
Cash, Cash Equivalents, and Short-term Investments 531M USD +11.2%
Assets, Current 580M USD +17.9%
Property, Plant and Equipment, Net 27K USD -60.3%
Operating Lease, Right-of-Use Asset 1.94M USD +594%
Other Assets, Noncurrent 315K USD +9%
Assets 582M USD +18.2%
Accounts Payable, Current 17.5M USD +63%
Employee-related Liabilities, Current 3.75M USD +35.9%
Accrued Liabilities, Current 18.7M USD +24%
Liabilities, Current 41.7M USD +60.6%
Operating Lease, Liability, Noncurrent 1.46M USD +1393%
Other Liabilities, Noncurrent 3.75M USD
Liabilities 67.2M USD +33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -683K USD -15%
Retained Earnings (Accumulated Deficit) -557M USD -45.7%
Stockholders' Equity Attributable to Parent 515M USD +16.5%
Liabilities and Equity 582M USD +18.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -39.7M USD -32%
Net Cash Provided by (Used in) Financing Activities 21M USD -93.5%
Net Cash Provided by (Used in) Investing Activities -79.9M USD -2046%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 105M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -98.6M USD -133%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 212M USD -13.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 679K USD +25.3%
Deferred Tax Assets, Valuation Allowance 108M USD +42.4%
Deferred Tax Assets, Gross 109M USD +42.8%
Operating Lease, Liability 2.31M USD +553%
Depreciation 9K USD -35.7%
Payments to Acquire Property, Plant, and Equipment 6K USD +50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -175M USD -46.9%
Lessee, Operating Lease, Liability, to be Paid 2.87M USD +661%
Operating Lease, Liability, Current 759K USD +339%
Lessee, Operating Lease, Liability, to be Paid, Year Two 917K USD +396%
Lessee, Operating Lease, Liability, to be Paid, Year One 774K USD +318%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 555K USD +2313%
Lessee, Operating Lease, Liability, to be Paid, Year Three 937K USD +13286%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 12.1M USD +664%
Lessee, Operating Lease, Liability, to be Paid, Year Four 240K USD
Additional Paid in Capital 1.07B USD
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 7K USD -72%
Deferred Tax Assets, Net of Valuation Allowance 715K USD +124%
Share-based Payment Arrangement, Expense 18.6M USD +43.6%
Operating Leases, Future Minimum Payments Due 105K USD -33.5%
Interest Expense 3.56M USD -12%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%